| Literature DB >> 30429945 |
Justin S Smith1,2,3, Adrian E Roitberg1, Olexandr Isayev4.
Abstract
In this Viewpoint, we discuss the current progress in applications of machine learning (ML) and artificial intelligence (AI) to meet the challenges of computational drug discovery. We identify several areas where existing methods have the potential to accelerate pharmaceutical research and disrupt more traditional approaches.Entities:
Year: 2018 PMID: 30429945 PMCID: PMC6231187 DOI: 10.1021/acsmedchemlett.8b00437
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345